TGF-beta1 and WISP-1/CCN-4 can regulate each other's activity to cooperatively control osteoblast function.

Area of Science:

• Biochemistry and Molecular Biology
• Cell Biology
• Bone Biology

Background:

• Wnt-induced secreted protein-1 (WISP-1), a CCN family member, is present in skeletal tissues, but its precise function in bone remains unclear.
• Two major WISP-1 transcripts, full-length and a variant (WISP-1va) lacking a TGF-beta binding site, were identified in human bone marrow stroma cells (hBMSC).

Purpose of the Study:

• To investigate the role of WISP-1 in modulating proliferation and osteogenic differentiation in hBMSC.
• To elucidate the functional relationship between WISP-1 and TGF-beta1 signaling in bone cells.

Main Methods:

• RT-PCR was used to analyze WISP-1 transcript expression in hBMSC.
• Recombinant human WISP-1 (rhWISP-1) and TGF-beta1 were applied to hBMSC cultures to assess proliferation (BrdU incorporation) and osteogenic differentiation (alkaline phosphatase activity).
• WISP-1 and WISP-1va variants were transfected into hBMSC, and TGF-beta1 signaling was assessed by monitoring Smad-2 phosphorylation.

Main Results:

• rhWISP-1 treatment enhanced hBMSC proliferation and alkaline phosphatase activity.
• rhWISP-1 attenuated TGF-beta1-induced proliferation and TGF-beta1 inhibited WISP-1-induced alkaline phosphatase activity.
• Both WISP-1 variants increased proliferation, but only influenced alkaline phosphatase activity in the presence of TGF-beta1, and rhWISP-1 reduced TGF-beta1-induced Smad-2 phosphorylation.

Conclusions:

• Full-length WISP-1 and WISP-1va act as modulators of proliferation and osteogenic differentiation in hBMSC.
• WISP-1 plays a regulatory role in TGF-beta1 signaling pathways within osteoblast-like cells.
• WISP-1 may represent a novel target for therapeutic intervention in bone-related disorders.